false
Catalog
2020 Webinar: Chronic Hepatitis C 101: The Basics
Chronic Hepatitis C 101: The Basics
Chronic Hepatitis C 101: The Basics
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The video transcript discusses the basics of treatment for hepatitis C. The presenters provide information on the epidemiology of hepatitis C, screening strategies, and the current treatment options. Hepatitis C is a global health problem, with an estimated 71 million people worldwide living with the disease. It can lead to liver damage and other complications if left untreated. Treatment options have significantly improved in recent years, with direct-acting antiviral medications achieving cure rates of over 95%. The presenters highlight specific treatment regimens such as Epclusa and Maviret, which are one pill a day for 12 weeks, and are effective for all genotypes of hepatitis C. The safety profile of these medications is generally good, with few side effects reported. The presenters note that screening for hepatocellular carcinoma should continue after treatment, especially in patients with advanced fibrosis or cirrhosis. Overall, the webinar emphasizes the effectiveness of current treatment options and the importance of screening and treating hepatitis C to prevent liver-related complications and reduce transmission of the virus.
Asset Caption
Moderator: Brian L. Pearlman, MD, FAASLD
Presenters: Lisa Catalli, MSN, NP-BC and Natarajan Ravendhran, MD, MBA, AGAF, FACG, FAASLD
Keywords
hepatitis C
treatment
epidemiology
screening strategies
direct-acting antiviral medications
cure rates
Epclusa
Maviret
complications
transmission
×
Please select your language
1
English